Comparison of male breast cancer in China and the US: a real-world cohort study
Abstract
Background: Male breast cancer (MBC) is a rare disease. Limited studies have investigated Chinese MBC patients or compared them with patients in other countries. This study aims to explore the features of Chinese MBC patients by comparing them with their American counterparts. Methods: We retrospectively collected data of Chinese MBC patients from 36 centers in China and American MBC patients from the Surveillance, Epidemiology, and End Results database, all of which were diagnosed between 1988 and 2020. Overall survival (OS) comparisons were evaluated by the Kaplan-Meier method, log-rank test, and Cox regression analyses. Results: 30.0%, P
Fields of Study & Subjects
Male Breast Health Studies
Breast Lesions and Carcinomas
Global Cancer Incidence and Screening
Publication details
- Journal / source
- Translational Breast Cancer Research
- Volume
- 7
- Pages
- 3–3
- Publication date
- 1 January 2026
- Language
- EN